VERRUGON Ointment Ref.[49659] Active ingredients: Salicylic acid

Source: Health Products Regulatory Authority (IE)  Revision Year: 2014  Publisher: Optima Consumer Health Ltd, Concept House, Brackenbeck Road, Bradford BD7 2LW, UK

4.3. Contraindications

Not to be used by patients with diabetes or those with severe circulatory disorders or peripheral neuropathy except following a doctor’s permission or recommendation.

Do not use if the verruca is already infected or surrounding skin is broken or inflamed.

Hypersensitivity to topical salicylate or any of the ingredients in Verrugon Ointment.

Do not use on moles, birthmarks, hairy warts or any other skin lesions for which Verrugon is not indicated.

4.4. Special warnings and precautions for use

Avoid contact with eyes or mucous membranes. If contact occurs flush with water for 15 minutes. Avoid contact with normal skin around the Verruca. Avoid using on areas of broken or damaged skin. Discontinue treatment if excessive irritation occurs.

Remove immediately any surplus ointment from normal skin tissue. Excessive prolonged use of topical salicylic acid may esult in symptoms of salicylism and therefore topical salicylic acid should not be used for prolonged periods, in high concentrations, on large areas of the body.

Wool fat in this ointment may cause local skin reactions (e.g. contact dermatitis).

4.5. Interaction with other medicinal products and other forms of interaction

There are no known interactions when used as indicated. However, salicylic acid may increase the absorption of other topically applied medicines. Concomitant use of Verrugon and other topical medicines should therefore be avoided.

4.6. Fertility, pregnancy and lactation

Whilst there are no known contra-indications to the use of Verrugon during pregnancy and lactation, the safety has not been established. Verrugon should therefore be used with caution or following professional advice.

4.7. Effects on ability to drive and use machines

Not applicable, none reported.

4.8. Undesirable effects

A localised irritant reaction may occur if Verrugon is applied to normal skin surrounding the Verruca. This may be controlled by temporarily discontinuing the use of Verrugon and by being careful to apply it only to the Verruca when treatment is resumed.

6.2. Incompatibilities

Not applicable.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.